Table of Contents
Global Non - insulin Diabetes Therapeutics Market Research Report 2021
1 Non - insulin Diabetes Therapeutics Market Overview
1.1 Product Overview and Scope of Non - insulin Diabetes Therapeutics
1.2 Non - insulin Diabetes Therapeutics Segment by Type (Product Category)
1.2.1 Global Non - insulin Diabetes Therapeutics Production and CAGR (%) Comparison by Type (Product Category)( 2016 - 2027)
1.2.2 Global Non - insulin Diabetes Therapeutics Production Market Share by Type (Product Category) in 2020
1.2.3 Alpha - glucosidase Inhibitors
1.2.4 Amylin Agonists
1.2.5 Biguanides
1.2.6 Dipeptidyl Peptidase - 4 (DPP4) Inhibitors
1.2.7 Glinides / Meglitinides
1.2.8 GLP - 1 Analogs / GLP - 1 Agonists
1.2.9 Sodium - glucose Cotransporter 2 (SGLT2) Inhibitors
1.2.10 Sulfonylureas
1.2.11 Thiazolidinediones
1.2.12 Others
1.3 Global Non - insulin Diabetes Therapeutics Segment by Application
1.3.1 Non - insulin Diabetes Therapeutics Consumption (Sales) Comparison by Application ( 2016 - 2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Non - insulin Diabetes Therapeutics Market by Region ( 2016 - 2027)
1.4.1 Global Non - insulin Diabetes Therapeutics Market Size (Value) and CAGR (%) Comparison by Region ( 2016 - 2027)
1.4.2 North America Status and Prospect ( 2016 - 2027)
1.4.3 Europe Status and Prospect ( 2016 - 2027)
1.4.4 China Status and Prospect ( 2016 - 2027)
1.4.5 Japan Status and Prospect ( 2016 - 2027)
1.4.6 Southeast Asia Status and Prospect ( 2016 - 2027)
1.4.7 India Status and Prospect ( 2016 - 2027)
1.5 Global Market Size (Value) of Non - insulin Diabetes Therapeutics ( 2016 - 2027)
1.5.1 Global Non - insulin Diabetes Therapeutics Revenue Status and Outlook ( 2016 - 2027)
1.5.2 Global Non - insulin Diabetes Therapeutics Capacity, Production Status and Outlook ( 2016 - 2027)
2 Global Non - insulin Diabetes Therapeutics Market Competition by Manufacturers
2.1 Global Non - insulin Diabetes Therapeutics Capacity, Production and Share by Manufacturers ( 2016 - 2021)
2.1.1 Global Non - insulin Diabetes Therapeutics Capacity and Share by Manufacturers ( 2016 - 2021)
2.1.2 Global Non - insulin Diabetes Therapeutics Production and Share by Manufacturers ( 2016 - 2021)
2.2 Global Non - insulin Diabetes Therapeutics Revenue and Share by Manufacturers ( 2016 - 2021)
2.3 Global Non - insulin Diabetes Therapeutics Average Price by Manufacturers ( 2016 - 2021)
2.4 Manufacturers Non - insulin Diabetes Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Non - insulin Diabetes Therapeutics Market Competitive Situation and Trends
2.5.1 Non - insulin Diabetes Therapeutics Market Concentration Rate
2.5.2 Non - insulin Diabetes Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Non - insulin Diabetes Therapeutics Capacity, Production, Revenue (Value) by Region ( 2016 - 2021)
3.1 Global Non - insulin Diabetes Therapeutics Capacity and Market Share by Region ( 2016 - 2021)
3.2 Global Non - insulin Diabetes Therapeutics Production and Market Share by Region ( 2016 - 2021)
3.3 Global Non - insulin Diabetes Therapeutics Revenue (Value) and Market Share by Region ( 2016 - 2021)
3.4 Global Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.5 North America Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.6 Europe Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.7 China Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.8 Japan Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.9 Southeast Asia Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.10 India Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
4 Global Non - insulin Diabetes Therapeutics Supply (Production), Consumption, Export, Import by Region ( 2016 - 2021)
4.1 Global Non - insulin Diabetes Therapeutics Consumption by Region ( 2016 - 2021)
4.2 North America Non - insulin Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.3 Europe Non - insulin Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.4 China Non - insulin Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.5 Japan Non - insulin Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.6 Southeast Asia Non - insulin Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
4.7 India Non - insulin Diabetes Therapeutics Production, Consumption, Export, Import ( 2016 - 2021)
5 Global Non - insulin Diabetes Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 Global Non - insulin Diabetes Therapeutics Production and Market Share by Type ( 2016 - 2021)
5.2 Global Non - insulin Diabetes Therapeutics Revenue and Market Share by Type ( 2016 - 2021)
5.3 Global Non - insulin Diabetes Therapeutics Price by Type ( 2016 - 2021)
5.4 Global Non - insulin Diabetes Therapeutics Production Growth by Type ( 2016 - 2021)
6 Global Non - insulin Diabetes Therapeutics Market Analysis by Application
6.1 Global Non - insulin Diabetes Therapeutics Consumption and Market Share by Application ( 2016 - 2021)
6.2 Global Non - insulin Diabetes Therapeutics Consumption Growth Rate by Application ( 2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Non - insulin Diabetes Therapeutics Manufacturers Profiles/Analysis
7.1 GSK
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 GSK Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Eli Lilly
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Eli Lilly Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Sumitomo Dainippon Pharma
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Sumitomo Dainippon Pharma Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Intarcia Therapeutics
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Intarcia Therapeutics Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Servier
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Servier Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.5.4 Main Business/Business Overview
7.6 Jiangsu Hansoh Pharmaceutical
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Jiangsu Hansoh Pharmaceutical Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Novo Nordisk Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 Emisphere
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Emisphere Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Uni - Bio Science Group
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Uni - Bio Science Group Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.9.4 Main Business/Business Overview
7.10 Takeda
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Non - insulin Diabetes Therapeutics Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Takeda Non - insulin Diabetes Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.10.4 Main Business/Business Overview
7.11 3SBio
7.12 Merck
7.13 Dong - A Pharmaceutical
7.14 Luye Pharma Group
7.15 Eurofarma
7.16 Geropharm
7.17 Alkem Labs
7.18 SatRx
7.19 Pfizer
7.20 Jiangsu Hengrui Medicine
8 Non - insulin Diabetes Therapeutics Manufacturing Cost Analysis
8.1 Non - insulin Diabetes Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non - insulin Diabetes Therapeutics
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Non - insulin Diabetes Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non - insulin Diabetes Therapeutics Major Manufacturers in 2020
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Non - insulin Diabetes Therapeutics Market Forecast ( 2021 - 2027)
12.1 Global Non - insulin Diabetes Therapeutics Capacity, Production, Revenue Forecast ( 2021 - 2027)
12.1.1 Global Non - insulin Diabetes Therapeutics Capacity, Production and Growth Rate Forecast ( 2021 - 2027)
12.1.2 Global Non - insulin Diabetes Therapeutics Revenue and Growth Rate Forecast ( 2021 - 2027)
12.1.3 Global Non - insulin Diabetes Therapeutics Price and Trend Forecast ( 2021 - 2027)
12.2 Global Non - insulin Diabetes Therapeutics Production, Consumption , Import and Export Forecast by Region ( 2021 - 2027)
12.2.1 North America Non - insulin Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.2 Europe Non - insulin Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.3 China Non - insulin Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.4 Japan Non - insulin Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.5 Southeast Asia Non - insulin Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.6 India Non - insulin Diabetes Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.3 Global Non - insulin Diabetes Therapeutics Production, Revenue and Price Forecast by Type ( 2021 - 2027)
12.4 Global Non - insulin Diabetes Therapeutics Consumption Forecast by Application ( 2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Non - insulin Diabetes Therapeutics
Figure Global Non - insulin Diabetes Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Production Market Share by Types (Product Category) in 2020
Figure Product Picture of Alpha - glucosidase Inhibitors
Table Major Manufacturers of Alpha - glucosidase Inhibitors
Figure Product Picture of Amylin Agonists
Table Major Manufacturers of Amylin Agonists
Figure Product Picture of Biguanides
Table Major Manufacturers of Biguanides
Figure Product Picture of Dipeptidyl Peptidase - 4 (DPP4) Inhibitors
Table Major Manufacturers of Dipeptidyl Peptidase - 4 (DPP4) Inhibitors
Figure Product Picture of Glinides / Meglitinides
Table Major Manufacturers of Glinides / Meglitinides
Figure Product Picture of GLP - 1 Analogs / GLP - 1 Agonists
Table Major Manufacturers of GLP - 1 Analogs / GLP - 1 Agonists
Figure Product Picture of Sodium - glucose Cotransporter 2 (SGLT2) Inhibitors
Table Major Manufacturers of Sodium - glucose Cotransporter 2 (SGLT2) Inhibitors
Figure Product Picture of Sulfonylureas
Table Major Manufacturers of Sulfonylureas
Figure Product Picture of Thiazolidinediones
Table Major Manufacturers of Thiazolidinediones
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Non - insulin Diabetes Therapeutics Consumption (K Units) by Applications ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Consumption Market Share by Applications in 2020
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Non - insulin Diabetes Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions ( 2016 - 2027)
Figure North America Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Europe Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure China Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Japan Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Southeast Asia Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure India Non - insulin Diabetes Therapeutics Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Capacity, Production (K Units) Status and Outlook ( 2016 - 2027)
Figure Global Non - insulin Diabetes Therapeutics Major Players Product Capacity (K Units) ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Capacity (K Units) of Key Manufacturers ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Capacity Market Share of Key Manufacturers ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Capacity (K Units) of Key Manufacturers in 2020
Figure Global Non - insulin Diabetes Therapeutics Capacity (K Units) of Key Manufacturers in 2021
Figure Global Non - insulin Diabetes Therapeutics Major Players Product Production (K Units) ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Production (K Units) of Key Manufacturers ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Production Share by Manufacturers ( 2016 - 2021)
Figure 2020 Non - insulin Diabetes Therapeutics Production Share by Manufacturers
Figure 2020 Non - insulin Diabetes Therapeutics Production Share by Manufacturers
Figure Global Non - insulin Diabetes Therapeutics Major Players Product Revenue (Million USD) ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue (Million USD) by Manufacturers ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue Share by Manufacturers ( 2016 - 2021)
Table 2020 Global Non - insulin Diabetes Therapeutics Revenue Share by Manufacturers
Table 2021 Global Non - insulin Diabetes Therapeutics Revenue Share by Manufacturers
Table Global Market Non - insulin Diabetes Therapeutics Average Price (USD/Unit) of Key Manufacturers ( 2016 - 2021)
Figure Global Market Non - insulin Diabetes Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2020
Table Manufacturers Non - insulin Diabetes Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Non - insulin Diabetes Therapeutics Product Category
Figure Non - insulin Diabetes Therapeutics Market Share of Top 3 Manufacturers
Figure Non - insulin Diabetes Therapeutics Market Share of Top 5 Manufacturers
Table Global Non - insulin Diabetes Therapeutics Capacity (K Units) by Region ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Capacity Market Share by Region ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Capacity Market Share by Region ( 2016 - 2021)
Figure 2020 Global Non - insulin Diabetes Therapeutics Capacity Market Share by Region
Table Global Non - insulin Diabetes Therapeutics Production by Region ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Production (K Units) by Region ( 2016 - 2021)
Figure Global Non - insulin Diabetes Therapeutics Production Market Share by Region ( 2016 - 2021)
Figure 2020 Global Non - insulin Diabetes Therapeutics Production Market Share by Region
Table Global Non - insulin Diabetes Therapeutics Revenue (Million USD) by Region ( 2016 - 2021)
Table Global Non - insulin Diabetes Therapeutics Revenue Market Share by Region ( 2016 - 2021)
Figure Global Non - insulin Diabete
